Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by fibrosis and impaired microcirculation, leading to damage to the skin and internal organs. The main pathogenetic mechanism is excessive collagen production, which leads to thickening and stiffening of connective tissues. The disease manifests itself in a variety of symptoms, including damage to the skin, joints, gastrointestinal tract, lungs, heart and kidneys. Systemic sclerosis can have different clinical forms, among which the limited and diffuse forms of the disease attract special attention, which directly affects the prognosis and consequences for the patient. Although the exact causes of SSc are not fully understood, it is believed that its development is influenced by genetic, immune and environmental factors.
History of the disease and interesting historical facts
Systemic sclerosis has been known to mankind since ancient times, as evidenced by references in a number of medical texts of ancient doctors. The ancient Greek physician Hippocrates mentioned "osclerotic" conditions, but the modern understanding of this disease began to form only in the 19th century. In 1864, the French physician Armand Trouvier first described the clinical picture of systemic sclerosis as a separate disease. Since then, the study of SSc has provided a wealth of useful information, which has received considerable attention from the medical community in the 20th and 21st centuries. In the 1980s, the first information was obtained about the genetic predisposition and immune processes involved in the pathogenesis of the disease. Interesting facts also concern the fact that in different historical eras, systemic sclerosis was perceived differently: from a mystical disease to a treatable condition with modern medical advances.
Epidemiology
Systemic sclerosis is a relatively rare disease, with a prevalence of 20 to 300 cases per 100,000 people depending on the region and ethnicity. According to international studies, women are diagnosed with SSc 3-4 times more often than men. The peak incidence is observed between the ages of 30 and 50, although cases of the disease system appearing in both children and the elderly have been described. About 10% patients have a family history of systemic sclerosis, which indicates possible genetic factors. Effective epidemiological studies have revealed that the incidence may vary depending on a combination of various factors, including environmental conditions and lifestyle.
Genetic predisposition to this disease
There is evidence of a genetic predisposition to the development of systemic sclerosis. Studies have found an association of the disease with several genes, with the most attention being drawn to HLA Class II and genes including the SSc type (i.e. sensitive to systemic sclerosis). An association has been reported with mutations in the COL1A1 and COL1A2 genes responsible for collagen synthesis, which may contribute to increased synthesis of connective tissue. Studies have pointed to potential markers predicting the risk of developing the disease. Despite this, the exact mechanisms of interaction between genetic predisposition and the external environment have not yet been fully elucidated. This represents an important area for further research.
Risk factors for the development of this disease
Risk factors that contribute to the development of systemic sclerosis include both physical and chemical exposures. They may include:
- Chemicals such as silicone, asbestos and solvents used in industry.
- Environmental factors such as solar radiation, atmospheric components.
- Viral infections (especially herpes viruses and other diseases).
- Genetic predisposition and family history.
- Hormonal changes, especially in women of reproductive age.
These factors can act both individually and interact with each other, creating favorable conditions for the development of the disease. It should also be mentioned that with age, the risk of developing SSc may increase, which makes regular medical examinations important for early detection and prognosis.
Diagnosis of this disease
Diagnosing systemic sclerosis is a complex process. The main symptoms that doctors look for often include:
- Skin changes such as thickening and hardening.
- Pain in joints and muscles.
- Gastrointestinal disorders (difficulty swallowing, diarrhea).
- Breathing problems and cardiovascular disease.
Laboratory tests include:
- Complete blood count, including determination of inflammatory marker levels.
- Autoantibodies (e.g., antibodies to centromeres, Scl-70, etc.).
Radiological tests, such as X-rays and CT scans, can help identify changes in the lungs and other organs. Other diagnostic tests may include pulmonary and cardiovascular function tests. Differential diagnosis includes ruling out other autoimmune diseases and connective tissue diseases, such as rheumatoid arthritis or systemic lupus erythematosus.
Treatment
Treatment of systemic sclerosis is multifactorial and depends on the clinical form and manifestations of the disease. General treatment may include:
- Recommendations for lifestyle changes (physical activity, giving up bad habits).
- Physiotherapy to improve joint function and reduce pain.
- Psychological support and counseling.
Pharmacological treatment includes:
- Nonsteroidal anti-inflammatory drugs for pain relief.
- Immunosuppressant drugs (methotrexate, azathioprine).
- Medicines that improve blood circulation (pentoxifylline, prostaglandins).
Surgical treatment may be required in cases where organ damage becomes critical (for example, when a kidney or hand transplant is needed). Other treatment options include the use of physical therapy, massage, diet therapy, and even traditional treatments.
List of medications used to treat this disease
The main drugs used to treat systemic sclerosis include:
- Methotrexate
- Hydroxychloroquine
- Dapoxetine
- Nifedipine
- Sildenafil
- Cyclophosphamide
Each drug is selected individually depending on the patient's condition and the severity of the disease.
Disease monitoring
Monitoring of systemic sclerosis involves regular check-ups to assess the dynamics of the disease and the effectiveness of treatment. The prognosis depends on multiple factors, including age, the degree of organ involvement, and the time of diagnosis. Some complications that may occur in patients with SSc include:
- Pulmonary hypertension
- Pulmonary fibrosis
- Disorders of the gastrointestinal tract (eg, reflux disease)
- Kidney problems (renal failure curve).
These complications can seriously impact the quality of life and survival of patients.
Age-related features of the disease
Systemic sclerosis has its own characteristics depending on the age group of patients. In children, the disease can manifest itself more aggressively, with rapid progression of symptoms. In older people, SSc is often accompanied by concomitant diseases, which complicates diagnosis and treatment. In middle age (from 30 to 50 years), the incidence is highest, and patients often present with a variety of symptoms that require a comprehensive approach to treatment.
Questions and Answers
- What are the main symptoms of systemic sclerosis? The main symptoms are thickening and hardening of the skin, joint pain, gastrointestinal disorders and respiratory problems.
- Can systemic sclerosis be hereditary? Yes, having a family history can increase your risk of developing systemic sclerosis, but genetic factors are only part of the picture.
- How is systemic sclerosis diagnosed? Diagnosis includes clinical manifestations, laboratory and radiological studies to assess the condition of organs.
- Are there effective treatments for systemic sclerosis? Treatment for SSD is individualized and may include medications, physical therapy, and surgery in severe cases.
- What is the prognosis for patients with systemic sclerosis? The prognosis depends on the degree of organ involvement and other factors. The disease can progress differently in each patient, and some patients can live for many years with a relatively good quality of life.
